SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-035322
Filing Date
2021-03-12
Accepted
2021-03-12 09:20:51
Documents
25
Period of Report
2021-03-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219565d1_8k.htm   iXBRL 8-K 26050
5 EXHIBIT 99.1 tm219565d1_ex99-1.htm EX-99.1 15403
6 GRAPHIC tm219565d1_ex99-1img001.jpg GRAPHIC 41338
7 GRAPHIC tm219565d1_ex99-1img002.jpg GRAPHIC 222325
8 GRAPHIC tm219565d1_ex99-1img003.jpg GRAPHIC 186629
9 GRAPHIC tm219565d1_ex99-1img004.jpg GRAPHIC 53439
10 GRAPHIC tm219565d1_ex99-1img005.jpg GRAPHIC 215995
11 GRAPHIC tm219565d1_ex99-1img006.jpg GRAPHIC 222771
12 GRAPHIC tm219565d1_ex99-1img007.jpg GRAPHIC 262359
13 GRAPHIC tm219565d1_ex99-1img008.jpg GRAPHIC 178772
14 GRAPHIC tm219565d1_ex99-1img009.jpg GRAPHIC 164997
15 GRAPHIC tm219565d1_ex99-1img010.jpg GRAPHIC 121583
16 GRAPHIC tm219565d1_ex99-1img011.jpg GRAPHIC 239357
17 GRAPHIC tm219565d1_ex99-1img012.jpg GRAPHIC 54651
  Complete submission text file 0001104659-21-035322.txt   2928181

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA casi-20210312.xsd EX-101.SCH 3187
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20210312_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20210312_pre.xml EX-101.PRE 22711
18 EXTRACTED XBRL INSTANCE DOCUMENT tm219565d1_8k_htm.xml XML 3590
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 21735629
SIC: 2836 Biological Products, (No Diagnostic Substances)